Barbara Wegiel

Barbara Wegiel, Ph.D., is currently an associate professor at Harvard Medical School and the Department of Surgery. She received her Ph.D. in Biochemistry at Jagiellonian University in Kracow, Poland, and Ph.D. in clinical sciences at Lund University in Sweden. She completed her postdoctoral training at Harvard Medical School in Dr. Leo Otterbein's laboratory. She is a recipient of a Scientist Development Grant from American Heart Association, as well as an Eleanor and Miles Shore HMS Fellowship. Dr. Wegiel’s research interests are focused on the molecular mechanisms of carcinogenesis. Her laboratory is interested in defining the role of heme degradation enzymes — heme oxygenase-1 and biliverdin reductase — and how they impact the tumor microenvironment.

Companies

• Associate Professor Harvard Medical School/BIDMC (2017)
• Assistant Professor Harvard Medical School/BIDMC (2011 — 2017)
• Instructor Beth Israel Deaconess Medical Center (2009 — 2011)

Education

• Harvard Medical School BIDMC (2007 — 2009)
• PhD Lund University (2005 — 2007)
• PhD Jagiellonian University (2004 — 2006)